135 related articles for article (PubMed ID: 14602139)
1. Association of genetic polymorphisms in CYP19 and CYP1A1 with the oestrogen receptor-positive breast cancer risk.
Miyoshi Y; Ando A; Hasegawa S; Ishitobi M; Yamamura J; Irahara N; Tanji Y; Taguchi T; Tamaki Y; Noguchi S
Eur J Cancer; 2003 Nov; 39(17):2531-7. PubMed ID: 14602139
[TBL] [Abstract][Full Text] [Related]
2. The association between genetic polymorphisms in CYP19 and breast cancer risk in Korean women.
Kim JY; Lee CS; Kim HO; Jo YH; Lee J; Jung MH; Baik HH; Choe W; Kang I; Yoon KS
Oncol Rep; 2009 Sep; 22(3):487-92. PubMed ID: 19639193
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms of estrogen synthesizing and metabolizing genes and breast cancer risk in Japanese women.
Miyoshi Y; Noguchi S
Biomed Pharmacother; 2003 Dec; 57(10):471-81. PubMed ID: 14637391
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms of estrogen-metabolizing genes and breast cancer risk: a multigenic study.
Han DF; Zhou X; Hu MB; Xie W; Mao ZF; Chen DE; Liu F; Zheng F
Chin Med J (Engl); 2005 Sep; 118(18):1507-16. PubMed ID: 16232327
[TBL] [Abstract][Full Text] [Related]
5. Association of genetic polymorphisms of ER-alpha and the estradiol-synthesizing enzyme genes CYP17 and CYP19 with breast cancer risk in Chinese women.
Zhang L; Gu L; Qian B; Hao X; Zhang W; Wei Q; Chen K
Breast Cancer Res Treat; 2009 Mar; 114(2):327-38. PubMed ID: 18629629
[TBL] [Abstract][Full Text] [Related]
6. Polymorphic variation in CYP19 and the risk of breast cancer.
Baxter SW; Choong DY; Eccles DM; Campbell IG
Carcinogenesis; 2001 Feb; 22(2):347-9. PubMed ID: 11181459
[TBL] [Abstract][Full Text] [Related]
7. A tetranucleotide repeat polymorphism in CYP19 and breast cancer risk.
Haiman CA; Hankinson SE; Spiegelman D; De Vivo I; Colditz GA; Willett WC; Speizer FE; Hunter DJ
Int J Cancer; 2000 Jul; 87(2):204-10. PubMed ID: 10861475
[TBL] [Abstract][Full Text] [Related]
8. The CYP19 TTTA repeat polymorphism is related to the prognosis of premenopausal stage I-II and operable stage III breast cancers.
Huang CS; Kuo SH; Lien HC; Yang SY; You SL; Shen CY; Lin CH; Lu YS; Chang KJ
Oncologist; 2008 Jul; 13(7):751-60. PubMed ID: 18614591
[TBL] [Abstract][Full Text] [Related]
9. BRCA1 breast cancer risk is modified by CYP19 polymorphisms in Ashkenazi Jews.
Raskin L; Lejbkowicz F; Barnett-Griness O; Dishon S; Almog R; Rennert G
Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1617-23. PubMed ID: 19366906
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in the human aromatase cytochrome P450 gene (CYP19) and breast cancer risk.
Healey CS; Dunning AM; Durocher F; Teare D; Pharoah PD; Luben RN; Easton DF; Ponder BA
Carcinogenesis; 2000 Feb; 21(2):189-93. PubMed ID: 10657957
[TBL] [Abstract][Full Text] [Related]
11. Variants in estrogen-biosynthesis genes CYP17 and CYP19 and breast cancer risk: a family-based genetic association study.
Ahsan H; Whittemore AS; Chen Y; Senie RT; Hamilton SP; Wang Q; Gurvich I; Santella RM
Breast Cancer Res; 2005; 7(1):R71-81. PubMed ID: 15642171
[TBL] [Abstract][Full Text] [Related]
12. CYP19 (TTTA)n polymorphism and breast cancer risk in Brazilian women.
Ribeiro FS; de Amorim LM; de Almeida Simão T; Mendonça GA; de Moura Gallo CV; Pinto LF
Toxicol Lett; 2006 Jun; 164(1):90-5. PubMed ID: 16406421
[TBL] [Abstract][Full Text] [Related]
13. Distinct prevalence of the CYP19 Delta3(TTTA)(7) allele in premenopausal versus postmenopausal breast cancer patients, but not in control individuals.
Suspitsin EN; Grigoriev MY; Togo AV; Kuligina ES; Belogubova EV; Pozharisski KM; Chagunava OL; Sokolov EP; Theillet C; Berstein LM; Hanson KP; Imyanitov EN
Eur J Cancer; 2002 Sep; 38(14):1911-6. PubMed ID: 12204674
[TBL] [Abstract][Full Text] [Related]
14. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
[TBL] [Abstract][Full Text] [Related]
15. CYP1A1, CYP19, and GSTM1 polymorphisms increase the risk of endometriosis.
Arvanitis DA; Koumantakis GE; Goumenou AG; Matalliotakis IM; Koumantakis EE; Spandidos DA
Fertil Steril; 2003 Mar; 79 Suppl 1():702-9. PubMed ID: 12620480
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphism of estrogen metabolizing enzymes in Siberian women with breast cancer.
Khvostova EP; Pustylnyak VO; Gulyaeva LF
Genet Test Mol Biomarkers; 2012 Mar; 16(3):167-73. PubMed ID: 21977969
[TBL] [Abstract][Full Text] [Related]
17. Association between CYP19 polymorphisms and breast cancer risk: results from 10,592 cases and 11,720 controls.
Ma X; Qi X; Chen C; Lin H; Xiong H; Li Y; Jiang J
Breast Cancer Res Treat; 2010 Jul; 122(2):495-501. PubMed ID: 20052540
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphisms of estrogen receptor alpha, CYP19, catechol-O-methyltransferase are associated with familial prostate carcinoma risk in a Japanese population.
Suzuki K; Nakazato H; Matsui H; Koike H; Okugi H; Kashiwagi B; Nishii M; Ohtake N; Nakata S; Ito K; Yamanaka H
Cancer; 2003 Oct; 98(7):1411-6. PubMed ID: 14508827
[TBL] [Abstract][Full Text] [Related]
19. A rare CYP19 (aromatase) variant may increase the risk of breast cancer.
Kristensen VN; Andersen TI; Lindblom A; Erikstein B; Magnus P; Børresen-Dale AL
Pharmacogenetics; 1998 Feb; 8(1):43-8. PubMed ID: 9511180
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer risk associated with polymorphism in CYP19 in Japanese women.
Miyoshi Y; Iwao K; Ikeda N; Egawa C; Noguchi S
Int J Cancer; 2000 Jul; 89(4):325-8. PubMed ID: 10956405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
